An Advance in Small-Cell Lung Cancer Treatment--More or Less
نویسندگان
چکیده
منابع مشابه
Sentinel Node Mapping in Non-small Cell Lung Cancer Using an Intraoperative Radiotracer Technique
Objective(s): Lymph node metastases are the most significant prognostic factor in localized non-small cell lung cancer (NSCLC). Identification of the first nodal drainage site (sentinel node) may improve detection of metastatic nodes. Extended surgeries, such as lobectomy or pneumonectomy with lymph node dissection, are among the therapeutic options of higher acceptab...
متن کاملUpdates in small cell lung cancer treatment.
Lung cancer is divided into two major histologic types: small cell lung cancer (SCLC) and non-small cell lung cancer. SCLC is rapidly progressive and, without treatment, may be fatal in as few as 12 weeks. Fortunately, SCLC is a very chemotherapy- and radiation-sensitive disease, and a variety of chemotherapy agents have demonstrated activity against it. This article provides an overview of SCL...
متن کاملRetreatment of patients surviving cancer-free 2 or more years after initial treatment of small cell lung cancer.
STUDY OBJECTIVE To assess the outcome after retreatment of patients with small cell lung cancer (SCLC) who redevelop small cell cancer (SCC) 2 or more years after initial therapy. DESIGN Retrospective analysis. SETTING Single government institution: the National Cancer Institute. PATIENTS Twenty patients who redeveloped SCC among 65 patients who survived 2 or more years after starting tre...
متن کاملLess is more… (more or less…).
In April 1981 Xerox introduced the Star 8010 workstation, the first commercial system with a Graphical User Interface (GUI) and the first to use the “desktop” metaphor to organize a user’s interactions with the computer. Despite the perception of huge progress, from the perspective of design and usage models, there has been precious little progress in the intervening years. In the tradition of ...
متن کاملSurvival and Prognostic Factors in Small Cell Lung Cancer Patients in Turkey
Background: Small cell lung cancer (SCLC) is a highly aggressive tumor. Objective: To evaluate the survival and time to progression of patients with SCLC admitted to a chest disease center in Istanbul, Turkey. Methods: Based on the reports of a pulmonary oncology clinic, data regarding performance status (PS), clinical stage of disease, treatment, time to progression and survival of 67 patients...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JNCI Journal of the National Cancer Institute
سال: 2003
ISSN: 0027-8874,1460-2105
DOI: 10.1093/jnci/djg013